NYSE · SI

Shoulder Innovations, Inc.

$20.96 +$0.55 (+2.69%) 1D Pre-market

Key Metrics

$423.27M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y 0.38
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved +16.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10
  • May 14
    The stock moved +15.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$423.27M
Enterprise value$329.69M
Shares outstanding20.7M
52-wk range$10.92 – $23.00
Avg volume · 20D2.4M
Net cash $93.58M
Book value / share$6.41
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNYSE
About Shoulder Innovations, Inc.
IPO dateJul 31, 2025
Employees75

Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio11.81
Quick ratio10.04
Debt / equity0.11
Debt / EBITDA
Net cash $93.58M
Working capital$133.44M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings